Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait

Journal of Neuroimmunology

Volumn 285, Issue , 2015, Pages 57-61

  Al Temaimi, Rabeah ^a   Alroughani, Raed ^b,c   Jacob, Sindhu ^a   Al Mulla, Fahd ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

EBNA1; Epstein Barr virus; HLA DRB1*1501; Kuwait; Multiple sclerosis; VCA

Indexed keywords

EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; HLA-DRB1*15:01 ANTIGEN;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENDER; GENETIC RISK; HAPLOTYPE; HUMAN; INCIDENCE; KUWAIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; YOUNG ADULT; ADOLESCENT; CELLULAR IMMUNITY; EPSTEIN BARR VIRUS; GENETICS; IMMUNOLOGY; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 4, HUMAN; HLA-DRB1 CHAINS; HUMANS; IMMUNITY, CELLULAR; KUWAIT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84943244238     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.05.021     Document Type: Article

References (31)

1. Al-Din A.S., Khogali M., Poser C.M., Al-Nassar K.E., Shakir R., Hussain J., Behbahani K., Chadha G. Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J. Neurol. Sci. 1990, 100:137-141.
2. Alroughani R., Ahmed S.F., Behbahani R., Khan R., Thussu A., Alexander K.J., Ashkanani A., Nagarajan V., Al-Hashel J. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult. Scler. 2014, 20:543-547.
3. Barcellos L.F., Sawcer S., Ramsay P.P., Baranzini S.E., Thomson G., Briggs F., Cree B.C., Begovich A.B., Villoslada P., Montalban X., Uccelli A., Savettieri G., Lincoln R.R., Deloa C., Haines J.L., Pericak-Vance M.A., Compston A., Hauser S.L., Oksenberg J.R. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 2006, 15:2813-2824.
4. Bordon Y. Autoimmunity: a breakthrough to explain sex bias?. Nat. Rev. Immunol. 2014, 14:355.
5. De Jager P.L., Simon K.C., Munger K.L., Rioux J.D., Hafler D.A., Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008, 70:1113-1118.
6. De Paschale M., Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J. Virol. 2012, 1:31-43.
7. Hillert J., Kall T., Vrethem M., Fredrikson S., Ohlson M., Olerup O. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. J. Neuroimmunol. 1994, 50:95-100.
8. Hislop A.D., Taylor G.S., Sauce D., Rickinson A.B. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 2007, 25:587-617.
9. Kakalacheva K., Munz C., Lunemann J.D. Viral triggers of multiple sclerosis. Biochim. Biophys. Acta 2011, 1812:132-140.
10. Kumar A., Melis P., Genna V., Cocco E., Marrosu M.G., Pieroni E. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility. Mol. Biosyst. 2014, 10:2043-2054.
11. Laichalk L.L., Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005, 79:1296-1307.
12. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 2010, 10:594-604.
13. Liguori M., Marrosu M.G., Pugliatti M., Giuliani F., De Robertis F., Cocco E., Zimatore G.B., Livrea P., Trojano M. Age at onset in multiple sclerosis. Neurol. Sci. 2000, 21:S825-S829.
14. Lucas R.M., Taylor B.V. Epstein-Barr virus infection: a smoking gun for multiple sclerosis?. Neurology 2012, 79:1310-1311.
15. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., Munz C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J. Exp. Med. 2008, 205:1763-1773.
16. Mameli G., Cossu D., Cocco E., Masala S., Frau J., Marrosu M.G., Sechi L.A. Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. J. Neuroimmunol. 2014, 270:51-55.
17. Marrosu M.G., Murru M.R., Costa G., Murru R., Muntoni F., Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Genet. 1998, 7:1235-1237.
18. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun. Rev. 2010, 9:A387-A394.
19. Mouhieddine T.H., Darwish H., Fawaz L., Yamout B., Tamim H., Khoury S.J. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. Clin. Immunol. 2015, 158:59-66.
20. Owens G.P., Bennett J.L. Trigger, pathogen, or bystander: the complex nexus linking Epstein-Barr virus and multiple sclerosis. Mult. Scler. 2012, 18:1204-1208.
21. Pender M.P. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 2011, 17:351-367.
22. Pender M.P., Burrows S.R. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin. Transl. Immunol. 2014, 3:e27.
23. Saha A., Robertson E.S. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin. Cancer Res. 2011, 17:3056-3063.
24. Santiago O., Gutierrez J., Sorlozano A., De Dios Luna J., Villegas E., Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29:857-866.
25. Schmidt H., Williamson D., Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 2007, 165:1097-1109.
26. Sundqvist E., Sundstrom P., Linden M., Hedstrom A.K., Aloisi F., Hillert J., Kockum I., Alfredsson L., Olsson T. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immunol. 2012, 13:14-20.
27. Sundstrom P., Nystrom M., Ruuth K., Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis. J. Neuroimmunol. 2009, 215:102-107.
28. Torring C., Andreasen C., Gehr N., Bjerg L., Petersen T., Hollsberg P. Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis. Acta Neurol. Scand. 2014, 130:90-96.
29. Toussirot E., Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 2008, 22:883-896.
30. Virtanen J.O., Jacobson S. Viruses and multiple sclerosis. CNS Neurol. Disord. Drug Targets 2012, 11:528-544.
31. Wu X.M., Wang C., Zhang K.N., Lin A.Y., Kira J., Hu G.Z., Qu X.H., Xiong Y.Q., Cao W.F., Gong L.Y. Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations. Mult. Scler. 2009, 15:1422-1430.